David C. Hancock - Concepedia

Author

David C. Hancock

The Honourable Society of Lincoln's Inn ORCID

Also Known As

D C Hancock, D Hancock, D. C. HANCOCK, D. C. Hancock, D. Hancock, D.C. Hancock, DAVID C HANCOCK, David C Hancock, David C. Hancock, David Hancock

116

Publications

7.6K

Citations

H-Index

Concepts

All Affiliations

The Honourable Society of Lincoln's Inn Cancer Research UK The Francis Crick Institute Institute of Cancer Research University of Cambridge

About

David C. Hancock is an author at The Honourable Society of Lincoln's Inn specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	5K
2	Health Sciences	3	3	300
3	Natural Sciences	3	3	88
4	Social Sciences	1	1	133
5	Allergy	1	1	19

David C. Hancock

Publications

7.5K

Citations

H-Index

Page 1

	Year	Citations
Induction of apoptosis in fibroblasts by c-myc protein Gérard I. Evan, Andrew H. Wyllie, Christopher S. Gilbert, Cell FibrosisCell RegulationApoptosisPathologyCell Death	1992	3K
A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins Trevor D. Littlewood, David C. Hancock, Paul S. Danielian, Nucleic Acids Research	1995	788
Identification of Novel Isoforms of the BH3 Domain Protein Bim Which Directly Activate Bax To Trigger Apoptosis Michela Marani, Tencho Tenev, David C. Hancock, Molecular and Cellular Biology Human Bim MrnaSignal TransductionSignaling PathwayCell RegulationNovel Isoforms	2002	285
The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer Madhu Kumar, David C. Hancock, Míriam Molina‐Arcas, Cell OncologyOncogenic AgentMedicineRadiation OncologyCancer Biology	2012	266
Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer Míriam Molina‐Arcas, Christopher Moore, Sareena Rana, Science Translational Medicine	2019	219
Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies Michael Steckel, Míriam Molina‐Arcas, Britta Weigelt, Cell Research Synthetic Lethal InteractionsTherapeutic Targeting StrategiesCancer BiologyTumor BiologyAnti-cancer Agent	2012	187
An Analysis of the Biological Properties of Monoclonal Antibodies against Glycoprotein D of Herpes Simplex Virus and Identification of Amino Acid Substitutions that Confer Resistance to Neutralization A. C. Minson, Charlie Hodgman, Paul Digard, Journal of General Virology VaccinationMolecular VirologyPathogenesisImmunologyGlycoprotein D	1986	184
Autophagy inhibition-mediated epithelial–mesenchymal transition augments local myofibroblast differentiation in pulmonary fibrosis Charlotte Hill, Juanjuan Li, Dian Liu, Cell Death and Disease	2019	169
Coordinate Direct Input of Both KRAS and IGF1 Receptor to Activation of PI3 kinase in <i>KRAS</i> -Mutant Lung Cancer Míriam Molina‐Arcas, David C. Hancock, Clare Sheridan, Cancer Discovery	2013	163
c-myc protein expression in untransformed fibroblasts. Catherine Waters, Trevor D. Littlewood, David C. Hancock, PubMed	1991	161

Page 1